Pediatric Vaccine Market
完整報告名稱與涵蓋範圍
Pediatric Vaccine Market Size, Share & Trends Analysis Report, By Vaccine Type (Monovalent Vaccines, Multivalent and Combination Vaccines), By Technology (Live Attenuated, Inactivated, Subunit and Conjugate, Toxoid, mRNA and Viral Vector), By Indication, By Region, and Segment Forecasts, 2026-2035
報告摘要
Pediatric vaccines protect infants, children, and adolescents against infectious diseases through scheduled immunization, and this market covers routine and catch-up doses delivered across public programs and private channels. The product landscape ranges from long-established live attenuated and toxoid formulations to conjugate polysaccharide products, hexavalent combinations that compress the infant schedule, and newer mRNA and monoclonal-adjacent approaches to respiratory pathogens.
Several forces are enlarging the opportunity. Pneumococcal conjugate franchises keep expanding serotype coverage, triggering commercial upgrades in already-vaccinated markets. Respiratory syncytial virus prevention has opened an entirely new infant category through maternal immunization and long-acting antibody strategies that sit alongside classical pediatric products. Combination vaccines continue to gain share because fewer injections improve schedule completion, a mechanism that matters most where clinic access is limited. Procurement structure is a defining feature: multilateral purchasers and national immunization programs buy at tiered prices, sustaining a dual market in which innovation-driven premium products coexist with high-volume supply from emerging-market manufacturers.
North America and Europe lead in value terms because premium conjugate and combination products dominate their schedules, while Asia Pacific and Africa dominate volume, with Indian and Chinese producers scaling WHO-prequalified supply. Vaccine hesitancy and periodic schedule debates present a demand risk unique to this category. Competition is consolidated among a handful of global innovators, flanked by fast-growing emerging-market suppliers.
The InsightAce study offers revenue forecasts in US$ across all vaccine type, technology, indication, and regional segments for 2026-2035, with segment-level trends, competitive landscape analysis, and company profiles.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pediatric Vaccine Market Snapshot
Chapter 4. Global Pediatric Vaccine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Vaccine Type Estimates & Trend Analysis
5.1. Vaccine Type & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Vaccine Type:
5.2.1. Monovalent Vaccines
5.2.2. Multivalent and Combination Vaccines
Chapter 6. Market Segmentation 2: By Technology Estimates & Trend Analysis
6.1. Technology & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Technology:
6.2.1. Live Attenuated Vaccines
6.2.2. Inactivated Vaccines
6.2.3. Subunit and Conjugate Vaccines
6.2.4. Toxoid Vaccines
6.2.5. mRNA and Viral Vector Vaccines
Chapter 7. Market Segmentation 3: By Indication Estimates & Trend Analysis
7.1. Indication & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Indication:
7.2.1. Pneumococcal Disease
7.2.2. Diphtheria Tetanus and Pertussis
7.2.3. Measles Mumps and Rubella
7.2.4. Rotavirus
7.2.5. Influenza
7.2.6. Hepatitis
7.2.7. Respiratory Syncytial Virus
7.2.8. Other Indications
Chapter 8. Pediatric Vaccine Market: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. United States
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. United Kingdom
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. South Korea
8.3.5. Australia
8.3.6. Southeast Asia
8.3.7. Rest of Asia Pacific
8.4. Latin America
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Rest of Latin America
8.5. Middle East & Africa
8.5.1. GCC Countries
8.5.2. South Africa
8.5.3. Rest of Middle East & Africa
Chapter 9. Competitive Landscape
9.1. Company Market Positioning Analysis
9.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 10. Company Profiles
10.1. Pfizer
10.2. GSK
10.3. Merck & Co.
10.4. Sanofi
10.5. Moderna
10.6. AstraZeneca
10.7. CSL Seqirus
10.8. Serum Institute of India
10.9. Bharat Biotech
10.10. Biological E
10.11. Panacea Biotec
10.12. Sinovac Biotech
10.13. Walvax Biotechnology
圖表清單 List of Tables & Figures
Table 1. Global Pediatric Vaccine Market Revenue Forecast by Vaccine Type, 2026-2035 (US$ Mn)
Figure 1. Global Pediatric Vaccine Market Segmentation Overview
Table 2. Global Pediatric Vaccine Market Revenue Forecast by Technology, 2026-2035 (US$ Mn)
Figure 2. Global Pediatric Vaccine Market Share by Technology, 2026 & 2035
Table 3. Global Pediatric Vaccine Market Revenue Forecast by Indication, 2026-2035 (US$ Mn)
Figure 3. Combination Vaccine Penetration Trend in Infant Immunization Schedules
Table 4. North America Pediatric Vaccine Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 4. Global Pediatric Vaccine Market Share by Indication, 2026 & 2035
Table 5. Europe Pediatric Vaccine Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Pneumococcal Conjugate Serotype Expansion Impact Analysis
Table 6. Asia Pacific Pediatric Vaccine Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Asia Pacific Pediatric Vaccine Growth Opportunity Analysis
Table 7. Latin America Pediatric Vaccine Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Respiratory Syncytial Virus Prevention Category Outlook
Table 8. Middle East & Africa Pediatric Vaccine Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Competitive Positioning of Key Pediatric Vaccine Participants
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們